Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.

Source:http://linkedlifedata.com/resource/pubmed/id/19185642

Download in:

View as

General Info

PMID
19185642